Journal of Gastroenterology

Article	Citations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom	115
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus	75
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism	73
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers	68
Bifidobacterium bifidum CIP-01 attenuates metabolic dysfunction-associated steatotic liver disease induced by high-alcohol-producing Klebsiella pneumoniae	62
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis	61
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease	56
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma	54
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy	49
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study	49
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	46
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv	44
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy	39
Single-cell transcriptomics unveils the immunologic landscape of anti-PD-1-associated indirect drug-induced liver injury	39
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan	37
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis	36
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data	36
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	36
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy	35
Clinicopathological features of localized-type IgG4-related cholecystitis: a nationwide multicenter study in Japan	33
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials	32
Clinical practice guidelines for duodenal cancer 2021	32
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan	32
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma	31
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database	31

Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices	30
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis	30
Acknowledgements	29
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey	29
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan	28
Correction: Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	28
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis	27
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan	27
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study	26
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?	25
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021	25
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis	24
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)	24
Evaluating liver reserve in direct-acting antiviral-treated hepatitis C patients: do we have better surrogate markers?	24
Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis”	23
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study	23
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation	22
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia	22
Is it necessary for endoscopic surveillance for achalasia patients?	22
Volatomics-based biomarkers for non-invasive diagnosis and monitoring of inflammatory bowel disease	21
Targeting autophagy as a therapeutic strategy against pancreatic cancer	21
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study	21
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime	21
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials	20
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study	20
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma	20
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”	20
An interpretable machine learning model for predicting survival in pancreatic cancer via SHAP: a multicenter study	19
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19	19
Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma	19
Clinicopathological features and prognosis of metastatic tumors in the small bowel: a large multicenter analysis of the JSCCR database in Japan	18
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection	18
Management of MASLD/MASH: challenges, innovations, and the future of patient-centered care in Japan	18
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases	18
Checking the shape of hepatocellular carcinoma: how irregular is irregular?	18
Letter to the editor to ‘‘Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis’’	18
Gastric cancer and genomics: review of literature	17
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?	17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway	17
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer	17
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”	16
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases	16
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)	16
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic	15
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society	15
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 2023	15
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease	15
HLA-DQB1*03:01 and HLA-DQA1*05:05 as key genetic determinants of infliximab response and immunogenicity in Japanese patients with inflammatory bowel disease	15
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry	14
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis	14

AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions	14
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma	14
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development	14
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)	14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy	14
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments	14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation	14
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia	14
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention	14
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan	13
Reply to “Comment on: Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan”	13
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY	13
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation	13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance	13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia	13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	13
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy	13
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando	13
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy	13
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study	13
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis	12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study	12
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance	12
Renal manifestations in inflammatory bowel disease: a systematic review	12
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data	12
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma	11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease	11
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis	11
Acknowledgements	11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer	11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia	11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study	11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer	11
Targeting the ZDHHC9-mediated STAT1 palmitoylation-phosphorylation conversion inhibits gastric cancer progression	10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”	10
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors	10
The antiferroptotic effect of indigo on ulcerative colitis	10
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co	10
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"	10
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer	10
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy	10
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis	10
Hepatocyte-specific yes-associated protein knockout exacerbates non-alcoholic steatohepatitis by upregulating PCSK9	10
Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients	10
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy	10
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis	9
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus	9
Comment on “Escherichia coli as a gut microbial marker of obesity and its reduction following bariatric treatment”: ecological and functional perspectives	9
Acknowledgements	9
Identification of the distal end of the palisade vessels under sedation: a multicenter prospective study in Japan	9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma	9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection	9
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenoc	9
Differences in adult eosinophilic esophagitis between Japan and Western countries	9
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease	9
Current status of type 1 (IgG4-related) autoimmune pancreatitis	9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer	9
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”	9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation	9
Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma	9
Predictors of lymph node metastases, recurrence, and survival in patients with pedunculated-type T1 colorectal cancer	9
Cost–utility analysis of treatment strategies for chronic constipation in Japan	9
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients	9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection	9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study	9
Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis	8
METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-κB pathway	8
Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia	8
Profile of plasma microRNAs as a potential biomarker of Wilson’s disease	8
LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression	8
Correction: LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice	8
Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502	8
Correction: Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	8
Reply to “Reappraisal of the MASLD predictive factors: insights beyond the surface”	8
Severity of surgical histopathological fibrosis predicted postoperative recurrence in Crohn’s disease: a multi-center retrospective cohort study	8
Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis, 1990–2019: a decomposition and age–period–cohort analysis	8
An endoscopic real-time, in situ assessment of intestinal permeability in type 2 diabetes: links to microbiota and hyperglycemia	8
Impact of early aggressive treatment on long-term biochemical marker patterns in inflammatory bowel disease	8

Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCRES	8
Long-term evaluation of Helicobacter pylori screening in school health checkups: an 11-year study in Japan	8
Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study	8
Accounting for resumption timing in evaluating the safety of oral anticoagulants following upper gastrointestinal endoscopic submucosal dissection	8
Reply to “IL-6 as a biomarker in atezolizumab plus bevacizumab in patients with hepatocellular carcinoma”	8
A novel artificial intelligence-based endoscopic ultrasonography diagnostic system for diagnosing the invasion depth of early gastric cancer	8
Serum Mac2-binding protein glycosylated isomer (M2BPGi) as a prognostic biomarker in pancreatic ductal adenocarcinoma: iCAFs-derived M2BPGi drives tumor invasion	8
Correction: Current status and future perspective of linked color imaging for gastric cancer screening: a literature review	8
Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases	8
Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials	8
Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review	7
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study	7
Impact of sarcopenia and changes in skeletal muscle mass on prognosis of patients with pancreatic ductal adenocarcinoma receiving chemotherapy with first-line gemcitabine and nab-paclitaxel: a prospec	7
Educational interventions to enhance support for balancing work and treatment in inflammatory bowel disease patients	7
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)	7
Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter random	7
An integrative multi-omics analysis reveals a multi-analyte signature of pancreatic ductal adenocarcinoma in serum	7
Lipidomics and single-cell transcriptomics uncover aberrant lipid metabolism in metaplasia lesions during gastric carcinogenesis	7
Red dichromatic imaging and linked color imaging as reliable image-enhanced endoscopic procedures for detecting the distal end of the palisade vessels in the columnar metaplastic mucosa of the gastroe	7
Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study	7
The magnetic resonance imaging and age-adjusted matrix metalloproteinase-7 assist the diagnosis of biliary atresia	7
The interplay between alterations in esophageal microbiota associated with Th17 immune response and impaired LC20 phosphorylation in achalasia	7
Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization	7
Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis	7
Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR	7
A clinicopathological study of IgG4-related autoimmune hepatitis and IgG4-hepatopathy	7
Long-term risk of inflammatory bowel disease in patients with irritable bowel syndrome: the cross-sectional and longitudinal relationship	7
Dietary vitamin D intake and risk of colorectal cancer according to vitamin D receptor expression in tumors and their surrounding stroma	7
CACNA2D1 regulates the progression and influences the microenvironment of colon cancer	7
Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression	7
Determination of optimal cutoff value of ulcerative colitis intestinal ultrasound index to estimate endoscopic improvement in ulcerative colitis	6
The vessels encapsulating tumor clusters (VETC) pattern is a negative predictor for first-line immune checkpoint inhibitors alone in unresectable hepatocellular carcinoma	6
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression	6
The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients	6
Prevalence and clinical impact of latent tuberculosis infection in patients with inflammatory bowel disease in Japan: a retrospective multicenter study by the IBD-Quality team	6
Reply to “Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis””	6
The clonal heterogeneity of colon cancer with liver metastases	6
Reply to ‘C-CAT's triumph in gastroenterology: the wisdom of cats is infinitely superior’	6
Pancreatic atrophy and recovery after allogeneic hematopoietic cell transplantation	6
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease	6
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases	6
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan	6
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria	6
Comment on “Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan”: methodological considerations regarding causality, subtyp	6
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study	6
Did the COVID-19 pandemic disrupt the continuity of post-SVR surveillance in HCV-cured patients?	6
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease	6
Molecular insights into HER2/ERBB2 amplification and carcinogenesis in gallbladder cancer associated with pancreaticobiliary maljunction	6
Immune checkpoint inhibitor-related pancreatitis: a comprehensive review of epidemiology, pathophysiology, and management	6
High-mobility group box 1: friend or foe in pancreatitis	6
The 2024 diagnostic criteria for primary sclerosing cholangitis	5
Current status of waitlist mortality and transplant probability for adult candidates with chronic end-stage liver disease for deceased donor liver transplantation under the Model for End-Stage Liver D	5
Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments	5
Efficacy and safety of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma patients with esophageal–gastric varices	5
Effect of tumor microenvironment in pancreatic cancer on the loss of β-cell mass: implications for type 3c diabetes	5
Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan	5
Autoantibodies against endothelial protein C receptor and integrin αvβ6 predict the development of ulcerative colitis	5
Factors associated with the development of bacterial pneumonia and the preventive potential of peroral endoscopic myotomy in patients with esophageal motility disorders: a case–control study	5
Cox proportional hazards regression reveals more than a 100-fold difference in cancer risk by the length of Barrett’s esophagus in Japan	5
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort	5
Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients	5
Development of gastric mucosa-associated microbiota in autoimmune gastritis with neuroendocrine tumors	5
Proportion of unresectable pancreatic cancer specimens obtained by endoscopic ultrasound-guided tissue acquisition meeting the OncoGuide™ NCC Oncopanel System analysis suitability criteria: a single-a	5
Formation of the pre-metastatic niche by COL9A1 + cancer-associated fibroblasts via SDC4 engagement promotes multi-organ metastasis in gastric cancer	5
Possibility of determining high quantitative fecal occult blood on stool surface using hyperspectral imaging	5
Does early intervention for infected pancreatic necrosis lead to better clinical outcomes compared to delayed intervention?	5
Development and validation of a claims-based algorithm to identify incidents and determine the progression phases of gastric cancer cases in Japan	5
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study	5
Importance of rectal over colon status in ulcerative colitis remission: the role of microinflammation and mucosal barrier dysfunction in relapse	5
Medium-chain and long-chain fatty acids are associated with diarrheal predominant irritable bowel syndrome revealed by DESI-MSI	4
Prospective pilot study of functional assessment of the Sphincter of Oddi via cine-dynamic MRCP with selective inversion recovery pulse	4
Future of gastric cancer elimination through Helicobacter pylori eradication therapy in Japan	4
Resistant starch reduces glycolysis by HK2 and suppresses high-fructose corn syrup-induced colon tumorigenesis	4
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study	4
Evolution of gallbladder drainage: a comprehensive review from percutaneous to endoscopic ultrasound-guided approaches	4
Nuclear magnetic resonance-based metabolomics and risk of pancreatic cancer: a prospective analysis in the UK Biobank	4
Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection	4
Clinical features and endoscopic polyp management of Peutz–Jeghers syndrome: the 2nd nationwide epidemiological survey in Japan	4
Performance of risk models in predicting outcomes of atezolizumab and bevacizumab therapy	4
Effect of a histamine-rich meal versus a low-histamine-containing meal on urinary histamine and N-methylhistamine excretion	4
Letter to the editor to “Long‑term outcome of PDT for local failure after CRT or RT for oesophageal cancer”	4
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis	4
Correction: The association between antigenemia, histology with immunohistochemistry, and mucosal PCR in the diagnosis of ulcerative colitis with concomitant human cytomegalovirus infection	4
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertension	4
Validation of the Japanese version of the Esophageal Hypervigilance and Anxiety Scale for esophageal symptoms	4
A phase I/II clinical trial of neoadjuvant docetaxel/oxaliplatin/S‑1 (DOS) combination therapy for gastroesophageal junction adenocarcinoma	4
Thiopurines exert harmful effects on spermatogenesis in Nudt15R138C knock-in mice	4
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicen	4
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program	4
Paired liver–spleen high-frequency ultrasound deep learning network for full-stage liver fibrosis classification and clinical benefit compared with 2D-SWE in chronic hepatitis B cohort: a prospective	4
Mortality and cancer in eosinophilic gastrointestinal disorders distal to the esophagus: nationwide cohort study 1990–2017	4
Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study	4
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy	3
Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial	3
A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion	3